HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Peter Sillevis Smitt Selected Research

Peter Sillevis Smitt Research Topics

Disease

3Neoplasms (Cancer)
01/2021 - 05/2015
3Paraneoplastic Cerebellar Degeneration
06/2012 - 06/2003
2Hodgkin Disease (Hodgkin's Disease)
06/2012 - 05/2010
2Cerebellar Ataxia (Dysmetria)
05/2010 - 06/2003
1Small Cell Lung Carcinoma (Small Cell Lung Cancer)
01/2021
1Cerebellar Diseases (Cerebellar Syndrome)
12/2020
1Encephalitis (Encephalitis, Rasmussen)
12/2020
1Neurologic Manifestations (Neurological Manifestations)
12/2020
1Dementia (Dementias)
12/2015
1Creutzfeldt-Jakob Syndrome (Creutzfeldt-Jakob Disease)
12/2015
1Autoimmune Diseases of the Nervous System
12/2015
1Ataxia (Dyssynergia)
05/2010
1Autoimmune Diseases (Autoimmune Disease)
05/2010
1B-Cell Lymphoma (Lymphoma, B Cell)
01/2006

Drug/Important Bio-Agent (IBA)

5AntibodiesIBA
01/2021 - 06/2003
2metabotropic glutamate receptor type 1IBA
12/2020 - 05/2010
2AntigensIBA
12/2015 - 06/2012
2AutoantibodiesIBA
06/2012 - 05/2010
1N 30IBA
12/2020
1Immunoglobulin G (IgG)IBA
12/2020
1Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA
12/2020
1Tyrosine Kinase InhibitorsIBA
06/2020
1ErbB Receptors (EGF Receptor)IBA
05/2015
1Epidermal Growth Factor (EGF)IBA
06/2012
1Rituximab (Mabthera)FDA Link
01/2006
1Monoclonal AntibodiesIBA
01/2006

Therapy/Procedure

1Therapeutics
05/2010